Fluorescent Human Claudin-6 / CLDN6 Full Length Protein (VLP)

AIDD‑Ready
Related Products: Cell line CHEK-ATP138
Cat. No. / Size
Price
Availability
Qty
CL6-HF2G8-20ug
$620.00
In Stock - Delivery in 1-2 business days
CL6-HF2G8-100ug
$1,235.00
In Stock - Delivery in 1-2 business days
CL6-HF2G8-500ug (250ug X 2)
$4,305.00
In Stock - Delivery in 1-2 business days
CL6-HF2G8
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Application
  • Immunization
  • Cell based assay (FACS or functional assay)
  • Screening (ELISA)
Synonyms

Claudin-6, CLDN6

Source

Fluorescent Human Claudin-6 Full Length Protein (VLP) (CL6-HF2G8) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Val 220 (Accession # P56747).

Predicted N-terminus: Asp

Molecular Characterization

This protein carries a GFP tag.

*The isotype control of empty/mock VLP (Cat. No. VLP-NF2P4) is sold separately and not included in protein, you can follow the link for product information.

Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

Synthesis Process

Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

Conjugate

GFP

Excitation source: 488 nm spectral line, argon-ion laser

Excitation Wavelength: 488 nm

Emission Wavelength: 530 nm

Purity

>95% as determined by SEC-HPLC.

Formulation

The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Shipping and Storage

This product is supplied and shipped on dry ice.

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • The product MUST be stored at -70°C or lower upon receipt;
  • -70°C for 12 months under sterile conditions.

Background

An oncofetal tight junction protein absent in normal adult tissues but aberrantly expressed in ovarian, endometrial, and testicular cancers. Its strict cancer specificity and extracellular accessibility make it an ideal candidate for CAR-T cell therapy and bispecific antibody development.